Roivant Sciences Ltd.
Price Action
Technical Summary
STAGE 2 UPTRENDRoivant Sciences Ltd. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings contraction of 265% provides fundamental context to the price action. However, price is extended 21% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $26.01 | +11.27% | ABOVE |
| 50 SMA | $23.83 | +21.43% | ABOVE |
| 100 SMA | $21.67 | +33.52% | ABOVE |
| 150 SMA | $18.80 | +53.92% | ABOVE |
| 200 SMA | $16.90 | +71.21% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ROIV in an uptrend right now?
ROIV has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, ROIV is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is ROIV overbought or oversold?
ROIV's RSI (14) is 72. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is ROIV outperforming the market?
ROIV has a Relative Strength (RS) Rating of 94 out of 99. Yes, ROIV is a market leader, outperforming 94% of all stocks over the past 12 months.
Where is ROIV in its 52-week range?
ROIV is trading at $28.94, which is 99% of its 52-week high ($29.20) and 99% above its 52-week low ($8.73).
How volatile is ROIV?
ROIV has a Beta of 0.81 and 52-week volatility of 40%. It's less volatile than the S&P 500 - generally more stable.